CAR-T Concept

1,737.83

+7.090.41%

Number of Gainers:2

Number of Losers:- -

Number of Flat:- -

PE:- -

High:1,755.66

Open:1,732.03

Low:1,731.68

Close:1,730.74

Volume:6.97M

Turnover:1.01B

Market Cap:447.86B

Float Cap:439.59B

Loading ...

Overview News

Novartis Trial Suspensions to Have Limited Financial Impact

Dow Jones

·

Sep 02

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4578/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T Concept","latestPrice":1737.8278,"timestamp":1789588799999,"preClose":1730.7407,"halted":0,"volume":6971298,"delay":0,"changeRate":0.004095,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":7.087036,"latestTime":"09-16 16:00:00 EDT","open":1732.0331,"high":1755.6616,"low":1731.6823,"amount":1014633876.993594,"amplitude":0.013855,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.351222,"peRate":46.833359,"turnoverRate":0.002257,"increases":2,"decrements":0,"flats":0,"marketCap":447863160832,"floatMarketCap":439585603584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1755.6616,"amplitude":0.013855,"preClose":1730.7407,"low":1731.6823,"pbRate":"8.351222","latestPrice":1737.8278,"volume":6971298,"delay":0,"open":1732.0331,"prevYearClose":1612.5378,"prevWeekClose":1707.2908,"prevMonthClose":1830.2803,"prevQuarterClose":1768.1697,"fiveDayClose":1719.0243,"twentyDayClose":1835.2719,"sixtyDayClose":1703.1655,"secType":"PLATE","market":"US","turnoverRate":0.002257,"peRate":46.833359,"marketCap":447863160832,"floatMarketCap":439585603584,"timestamp":1789588799999,"nameCN":"CAR-T Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":2,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664920892","title":"Novartis Trial Suspensions to Have Limited Financial Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2664920892","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664920892?lang=en_us&edition=fundamental","pubTime":"2026-09-02 16:15","pubTimestamp":1788336900,"startTime":"0","endTime":"0","summary":"0815 GMT - Novartis's decision to suspend several clinical trials for a cell therapy after three patients died is expected to have a limited financial impact, Citi analysts say in a research note. Pending further updates, the news reduces the likelihood that the Swiss drugmaker's next-generation cell-therapy platform--which aims to accelerate the process of T-cell expansion to treat autoimmune diseases--could provide a future boost, the analysts say. However, the treatment was still in midstage trials, and Citi's current peak sales estimate stands at only $440 million. Novartis shares fall 0.6%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","IE0009355771.USD","IE00B4R5TH58.HKD","BK4532","IE00BJJMRZ35.SGD","NVS","LU0211331839.USD","MEDX","IE0002141913.USD","IE00BJT1NW94.SGD","BK4578","BK4588","LU0320765489.SGD","BK4007","LU0070302665.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4585","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":101,"code":"91000000","status":"200"}]}}